Skip to main content

nSTRIDE APS

nSTRIDE APS

Saline-controlled study of nSTRIDE APS for knee osteoarthritis

Associated Conditions

Osteoarthritis

Principal Investigator

Sponsor

Biomet Biologics, LLC

This trial is to evaluate the safety and clinical effectiveness of autologous protein solution, prepared from a small sample of your blood with an investigational device, on pain and function associated with knee osteoarthritis. Half of the study participants will receive the treatment injection and half will receive a saline injection. You will not know which injection you received until the end of the study. Dr. J. Dean Cole serves as the Principal Investigator on this Zimmer Biomet sponsored study.